89 results
Page 4 of 5
424B5
hnh6mplxg1dlrz7kjoj
3 Oct 19
Prospectus supplement for primary offering
4:11pm
424B5
w6q39mezu tv4
3 Oct 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
cjguf12i0
21 Mar 19
Ovid Therapeutics Announces Appointment of Pharmaceutical Veteran, Thomas Perone, as Senior Vice President, General Counsel and Corporate Secretary
8:02am
424B5
znafhx2 rqv0h7
21 Feb 19
Prospectus supplement for primary offering
9:24pm
424B5
v4wcq06wawyn
21 Feb 19
Prospectus supplement for primary offering
9:22pm
8-K
EX-1.1
5m9g49
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
8-K
EX-1.2
nwpgwy0wmmectpr
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
424B5
0i416 vl0qq362n
19 Feb 19
Prospectus supplement for primary offering
4:06pm
424B5
jolb1w39xf0yjuz68i8
19 Feb 19
Prospectus supplement for primary offering
4:04pm
S-3
EX-4.6
0spl g5pg
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.7
rrj8gk1q l4g
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.8
62c0efuqu4l2nz
1 Jun 18
Shelf registration
5:14pm
S-3
ayxv4q4k
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.4
tamsy7 taytux
1 Jun 18
Shelf registration
5:14pm